Drug of choice for hypeension with hyperlipidemia is
**Question:** Drug of choice for hypertension with hyperlipidemia is
A. ACE inhibitors
B. Angiotensin II receptor blockers (ARBs)
C. Statins
D. Calcium channel blockers
**Core Concept:** In patients with hypertension and associated hyperlipidemia, the selection of antihypertensive medication depends on the underlying pathophysiology and clinical context.
**Why the Correct Answer is Right:** ACE inhibitors (e.g., ramipril, lisinopril) are effective in both hypertension and hyperlipidemia treatment. They primarily target the renin-angiotensin-aldosterone system (RAAS), which helps lower blood pressure and improve lipid profiles by increasing HDL cholesterol levels and reducing LDL cholesterol levels.
**Why Each Wrong Option is Incorrect:**
A. Angiotensin II receptor blockers (ARBs): These drugs (e.g., losartan, valsartan) also target the RAAS, but they do not have significant lipid-modifying effects compared to ACE inhibitors.
B. Calcium channel blockers (e.g., amlodipine, nifedipine): Although these drugs help lower blood pressure, their effect on lipid profiles is minimal or negligible.
C. Statins: These drugs (e.g., atorvastatin, simvastatin) primarily target hyperlipidemia by inhibiting HMG-CoA reductase, leading to cholesterol reduction and improvement in lipid profiles. While statins may also lower blood pressure, their effect is less pronounced compared to ACE inhibitors.
**Clinical Pearl:** The combination of ACE inhibitors and statins is often used to treat hypertension and hyperlipidemia simultaneously, as they provide synergistic benefits on blood pressure control and lipid profiles. However, the choice between ACE inhibitors and ARBs depends on the specific patient's condition and risk factors. In general, ACE inhibitors are preferred for their superior lipid-modifying effects.
**Correct Answer:** ACE inhibitors (e.g., ramipril, lisinopril) are the drug of choice for hypertension and hyperlipidemia management due to their significant impact on blood pressure and lipid profiles.